The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot single-arm, pragmatic trial in progress of in-home versus in-clinic subcutaneous nivolumab administration through Cancer Care (connected access and remote expertise) Beyond Walls (CCBW) program.
 
Dina Elantably
No Relationships to Disclose
 
Jeremy Jones
No Relationships to Disclose
 
Yanyan Lou
Consulting or Advisory Role - AstraZeneca; Janssen; Lilly; Turning Point Therapeutics
Research Funding - Blueprint Medicines (Inst); Daiichi-Sankyo (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Tolero Pharmaceuticals (Inst)
 
Gina Mazza
Research Funding - Bristol Myers Squibb Foundation (Inst); Pfizer (Inst)
 
Chanice Howard
No Relationships to Disclose
 
Sunnie Confiado
Employment - Mayo Clinic
 
Amber Baskin
Employment - Mayo Clinic
 
Alexis Jackson
No Relationships to Disclose
 
Angela Fritsche
Employment - Mayo Clinic Cancer Center
Honoraria - Johns Hopkins University
(OPTIONAL) Uncompensated Relationships - Association of American Cancer Institutes; Society for Clinical Research Sites, Oncology Board
 
Kaila Lopez
No Relationships to Disclose
 
Jade Brown
No Relationships to Disclose
 
Luci Nolan
Employment - Curant Health (I); Mayo Clinic; UFHealth; UFHealth (I)
Travel, Accommodations, Expenses - Mayo Clinic
 
Dustin Chapin
No Relationships to Disclose
 
Gregory Beliles
No Relationships to Disclose
 
Nathan Smith
No Relationships to Disclose
 
Winston Tan
Honoraria - Medscape; Onclive
 
Mohamed Kharfan-Dabaja
Honoraria - Kite/Gilead
Research Funding - Bristol Myers Squibb (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Grzegorz Nowakowski
Consulting or Advisory Role - Abbvie; Bantam Pharmaceutical; Bristol-Myers Squibb/Celgene; Celgene (Inst); Debiopharm Group; Genentech (Inst); Genmab; Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Roche Pharma AG (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Cheryl Willman
Patents, Royalties, Other Intellectual Property - Patents related to genomic diagnostics for cancer
 
Roxana Dronca
Honoraria - BMS; BMS; BMS (Inst); Eisai; Elsevier; EMD Serono; Natera; Replimune
Consulting or Advisory Role - BMS; BMS; BMS (Inst); Eisai; Elsevier; EMD Serono; Genzyme; Natera; Replimune
Research Funding - Alkermes (Inst); BMSi (Inst); BMSi (Inst); Emerson Collective (Inst); Merck Sharp & Dohme (Inst); Phosplatin Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); Spirita (Inst)
Patents, Royalties, Other Intellectual Property - Development of a Novel CAR-T Therapy to Tackle the Challenges of Immune Evasion
Travel, Accommodations, Expenses - BMSi; Replimune
Other Relationship - Elsevier